Robert Engler - Professor of Medicine Emeritus @ University of California San Diego

Overview

Number of Current Board & Advisor Roles

Number of Founded Organizations

Primary Job Title Professor of Medicine Emeritus
Primary Organization
University of California San Diego

Location La Jolla, California, United States
Regions Greater San Diego Area, West Coast, Western US
Gender Male

LinkedIn View on LinkedIn

Robert L. Engler is based out of La Jolla, California, and is the chief medical advisor of Cardium Therapeutics. Robert previously worked at the VA Hospital as an associate chief of staff for research and development. Robert L. Engler attended Georgetown University.

Jobs

Number of Current Jobs

Number of Past Jobs

Robert Engler

is the

Professor of Medicine Emeritus

University of California San Diego

. Additionally,

Robert Engler

has had

past jobs including

Professor of Medicine

University of California San Diego

University of California San Diego Professor of Medicine Emeritus

Organization Name	Title At Company	Start Date	End Date
University of California San Diego	Professor of Medicine	1975	2001
Schering AG	Founder (Collateral Therapeutics)	—	—

Board and Advisor Roles

Number of Current Board & Advisor Roles

Number of Past Board & Advisor Roles

Robert Engler

is the

Chief Medical Advisor

Cardium Therapeutics

Cardium Therapeutics Chief Medical Advisor

Organization Name	Title At Company	Start Date	End Date
Verdezyne	Board of Directors	—	2014

Related Hubs

Hub Name	CB Rank (Hub)
United States STEM Education Companies	18,017
Western US Education Companies (Top 10K)	2,186
Education Female Founded Companies	20,672
Greater San Diego Area Companies With More Than 50 Employees	12,524
West Coast Education Female Founded Companies	64,100
National Cancer Institute Portfolio Companies	83,103
Education Companies With More Than 1000 Employees	2,597
Higher Education Companies With More Than 10 Employees	7,812
Greater San Diego Area Companies With More Than $10M in Revenue	17,854
National Institute on Drug Abuse (NIDA) Portfolio Companies	88,909